Dr. Cliff Weiss, the Director of IR Research at Johns Hopkins, dives into the promising realm of bariatric arterial embolization (BAE) for obesity treatment. He discusses how BAE can enhance weight loss efforts alongside surgical and pharmaceutical options. Highlighting his research on ghrelin's effect on hunger, Dr. Weiss explains the technique involves targeted embolization using specific spheres. He shares findings from notable trials, revealing that patients often achieve significant weight loss around six to nine months post-procedure, reshaping obesity management strategies.